Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kogene Biotech is a South Korea-based molecular diagnostics and in vitro diagnostics company focused on real-time PCR and conventional PCR assay products. The company develops and commercializes diagnostic kits for human infectious diseases, including SARS-CoV-2, influenza, RSV, broader respiratory virus panels, gastrointestinal pathogens, and bacterial pneumonia, and it also offers solutions for food safety, animal disease, and environmental testing. Kogene markets its assays and sample-preparation products under brands such as PowerChek and PowerPrep, positioning itself as a total-solution provider from extraction through detection. The company became especially visible during the COVID-19 pandemic through early commercialization of SARS-CoV-2 PCR kits, including products that received Korean and international regulatory clearances. Overall, Kogene Biotech appears to be a revenue-generating commercial diagnostics company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kogene Biotech.